Oversees improvements to operations and technology processes by: forecasting and determining the direction of future strategic projects, providing oversight for multiple internal and external strategic projects designed to remediate issues and improve quality, service, affordability, and/or operating efficiency; using broad trends from analysis across operations processes to identify new practices to optimize the performance of operations system processes and address quality and safety issues; overseeing the development and implementation of strategic plans with the goal of achieving integrated services across the continuum of care in alignment with long-term enterprise-wide goals; and consulting with executive management for the effective integration of performance metrics to monitor the success of strategic improvement projects across the organization. Director partners with The Permanente Medical Group (TPMG), Regional Patient Care Services (PCS), Pharmacy, Laboratory Services, Clinical Education, Quality, Clinical Informatics, and operational leaders to successfully implement and scale advanced oncology therapies including CAR-T, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Gene Therapy, Bone Marrow Transplant (BMT), chemotherapy, immunotherapy, and home infusion oncology services.